Delta Asset Management LLC Catalent, Inc. Transaction History

Delta Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $4,139 - $8,100	100 New	100 $4,000
Q1 2022 May 12, 2022	SELL	$94.19 - $124.49 $32,966 - $43,571	-350 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$119.57 - $139.07 $2,989 - $3,476	-25 Reduced 6.67%	350 $45,000
Q2 2020 Jul 23, 2020	SELL	$48.02 - $79.04 $2,785 - $4,584	-58 Reduced 13.39%	375 $27,000
Q3 2019 Oct 31, 2019	BUY	$47.45 - $58.05 $20,545 - $25,135	433 New	433 $21,000
Q1 2019 Apr 30, 2019	SELL	$29.84 - $43.92 $1,671 - $2,459	-56 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$33.75 - $41.67 $1,890 - $2,333	56	56 $2,000

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Asset Management LLC with notifications on news.